Adrianna Jaślikowska

Adrianna Jaślikowska

Auto-generated profile, based on publicly available information

Adrianna Jaślikowska

Military Clinical Hospital with the Polyclinic SPZOZ in Lublin, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2026 in Quality in Sport
Verified
Journal Article
Open access
WGWeronika Grzyb
Weronika Grzyb
DGDominika Grzybowska
Dominika Grzybowska
MKMichał Kurnik
Michał Kurnik
JRJakub Rzeszutek
Jakub Rzeszutek
NNNatalia Niderla
Natalia Niderla
AJAdrianna Jaślikowska
Adrianna Jaślikowska
Background: Understaffing in healthcare occurs when the number of available workers is insufficient to meet patient care and organizational demands. Driven by population aging, chronic disease prevalence, workforce migration, inadequate planning, and the COVID-19 pandemic, staff shortages have become a major global challenge. Understaffing increases workload, time pressure, and emotional demands, raising the risk of serious psychological consequences affecting both worker well-being and quality of care. Aim: The aim of this narrative review was to examine the psychological consequences of understaffing, analyze its impact on the mental health of healthcare professionals, and identify potential preventive strategies. Material and Methods: A narrative review was conducted using the PubMed, Scopus, and Google Scholar databases. Peer-reviewed articles addressing the psychological outcomes of understaffing among healthcare workers were identified using predefined keywords, screened by title and abstract, reviewed in full text, and analyzed thematically. Results: The literature consistently identified burnout—comprising emotional exhaustion, depersonalization, and reduced personal accomplishment—as the most prominent psychological consequence of understaffing. Staff shortages were also linked to stress, anxiety, depression, sleep deprivation, moral distress, and compassion fatigue. At the system level, understaffing contributed to absenteeism, turnover intention, medical errors, lower quality of care, and patient dissatisfaction, creating a self-perpetuating cycle. Conclusions: Understaffing is both an organizational and public health concern with serious psychological consequences for healthcare professionals. Effective staffing policies, organizational and leadership support, mental health services, resilience programs, and improved work-life balance are essential for protecting worker well-being and ensuring sustainable healthcare delivery.

11 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NRNatalia Rachwał
Natalia Rachwał
KSKatarzyna Sikora
Katarzyna Sikora
NNNatalia Niderla
Natalia Niderla
JRJakub Rzeszutek
Jakub Rzeszutek
WGWeronika Grzyb
Weronika Grzyb
AKAdrian Kubicki
Adrian Kubicki
Background: Sleep is a fundamental biological process essential for physical and mental health. Adequate sleep supports metabolic balance, immune function, cognitive performance, and emotional regulation. Chronic sleep insufficiency, however, is a major health burden. There is accumulating evidence to suggest that low magnesium intake and subclinical magnesium deficiency may be associated with poor sleep quality and an increased risk of insomnia. Aim: The aim of this study was to analyze the mechanisms of magnesium action in the body that may influence our sleep health and summarise the available scientific literature on the subject. Materials and methods: A narrative review was performed using PubMed and Google Scholar databases. In total, 29 publications were included, focusing on systematic reviews, meta-analyses, and randomized controlled trials. Results: The reviewed studies show an association between higher magnesium levels and better sleep efficiency. Clinical trials reported modest improvements in sleep quality among groups that either supplemented or had higher dietary intake of Mg compared to placebo. The limitations of most presented trials include relatively small populations and short durations. Conclusions: The reviewed evidence indicates that low magnesium status is associated with fragmented or nonrestorative sleep, while magnesium supplementation may provide modest improvements in sleep outcomes. Future work should clarify optimal dosages and formulations and identify which populations (e.g. older adults, individuals experiencing stress, or those with inflammatory conditions) benefit the most from Mg supplementation.

26 June 2026 in Quality in Sport
Verified
Journal Article
Open access
KIKamil Idzik
Kamil Idzik
JRJakub Rzeszutek
Jakub Rzeszutek
WPWiktoria Pempuś
Wiktoria Pempuś
DGDominika Grzybowska
Dominika Grzybowska
NNNatalia Niderla
Natalia Niderla
AKAdrian Kubicki
Adrian Kubicki
Glaucoma is a leading cause of irreversible blindness, and psychiatric patients are at increased risk of ocular adverse effects from pharmacotherapy; this review summarizes the safety of psychiatric medications with respect to glaucoma type, including open-angle and angle-closure forms. A search of PubMed, Scopus, and Web of Science covering studies from 2020 to 2026, including observational studies, meta-analyses, and systematic reviews, assessed associations between psychiatric drugs, glaucoma risk, and intraocular pressure. Selective serotonin reuptake inhibitors demonstrate a favorable profile in open-angle glaucoma, with modest intraocular pressure reduction and decreased risk, whereas benzodiazepines are associated with increased glaucoma risk, particularly in angle-closure glaucoma. Topiramate shows a strong association with acute angle-closure glaucoma, while tricyclic antidepressants, despite anticholinergic effects, do not consistently increase glaucoma risk. Antipsychotics, especially olanzapine, may precipitate acute angle closure, whereas lithium appears neutral or potentially protective. Overall, psychiatric medications exhibit heterogeneous ophthalmic safety, and particular caution is warranted with topiramate and benzodiazepines in patients with narrow angles or angle-closure glaucoma, alongside regular ophthalmologic monitoring.

12 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DGDominika Grzybowska
Dominika Grzybowska
WGWeronika Grzyb
Weronika Grzyb
KIKamil Idzik
Kamil Idzik
AJAdrianna Jaślikowska
Adrianna Jaślikowska
AKAdrian Kubicki
Adrian Kubicki
JRJakub Rzeszutek
Jakub Rzeszutek
Introduction and purpose: Wearable technologies have become widely adopted tools for monitoring physical activity and optimizing athletic training, yet comprehensive evaluations of their accuracy and effectiveness remain fragmented. This systematic review synthesizes evidence on wearable technology in physical activity monitoring and sport-specific training. Materials and methods: A systematic search of PubMed, Embase, Web of Science, SPORTDiscus, and CENTRAL was conducted for studies published between 2015 and 2025, following PRISMA 2020 guidelines. Systematic reviews, meta-analyses, and primary validation studies were synthesized. Brief description of the state of knowledge: Step counting reached acceptable accuracy in leading consumer devices (mean absolute percentage error below 25%), and optical heart rate sensors performed well at rest and moderate intensity (MAPE below 10%). Energy expenditure estimation remained inaccurate across all devices (MAPE exceeding 30%). An umbrella review of 39 systematic reviews found that 79% of physical activity analyses favored wearable interventions. A meta-analysis of 23 trials involving 4,566 older adults reported significant improvements in daily step counts and physical activity time, whereas no significant effects were found in youth populations. Summary: Wearable devices offer acceptable accuracy for step counting and heart rate but not energy expenditure. Standardized validation protocols, algorithmic transparency, and long-term effectiveness studies are needed to maximize clinical and sporting utility.

31 August 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
NNNatalia Niderla
Natalia Niderla
JRJakub Rzeszutek
Jakub Rzeszutek
AKAdrian Kubicki
Adrian Kubicki
NRNatalia Rachwał
Natalia Rachwał
KOKarolina Obuchowska
Karolina Obuchowska
WGWeronika Grzyb
Weronika Grzyb
Crohn’s disease is an inflammatory bowel disease, which substantially impairs patients’ quality of life. Despite ongoing advances, effective long-term management remains challenging in many cases. Conventional therapies are often associated with significant adverse effects and limited suitability for sustained use. This review provides an overview of the current landscape of novel biological therapeutics and their molecular targets. Several biologic therapies are already well established in clinical practice. Among them, IL-23 inhibitors stand out due to their high efficacy in both inducing and maintaining remission. Agents targeting the TL1A pathway, as well as human amniotic epithelial cells have shown promising early results and are currently under further investigation in clinical trials. Nevertheless, discontinuation of some biologics trials proves that not all theoretically attractive targets translate into meaningful clinical outcomes. Importantly, variability in efficacy can be observed even within the same class of drugs. This is exemplified by the success of upadacitinib in contrast to tofacitinib, which did not meet primary endpoints and was not further developed for this indication. Overall, these findings highlight both the progress achieved and the ongoing challenges in optimizing targeted therapies for Crohn’s disease.

29 September 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AKAdrian Kubicki
Adrian Kubicki
MMMałgorzata Maj
Małgorzata Maj
NNNatalia Niderla
Natalia Niderla
JRJakub Rzeszutek
Jakub Rzeszutek
NRNatalia Rochwał
Natalia Rochwał
KIKamil Idzik
Kamil Idzik
Background: Obesity has become a global civilization-related disease and constitutes an independent risk factor for numerous somatic disorders. Obesity can contribute to depression through low self-esteem, body image concerns, and stigmatization, while depression and chronic stress may promote obesity through emotional eating and binge eating. Both conditions share biological mechanisms, including HPA axis dysregulation, elevated cortisol levels, and chronic inflammation. Effective management requires an interdisciplinary approach that combines weight-loss interventions with psychological treatment. Weight reduction is associated with improved mood and quality of life. Aim: The aim of this narrative review is to analyze and synthesize the current state of knowledge regarding the relationship between obesity and depression. The paper seeks to identify the biological and psychological mechanisms linking both conditions, as well as to assess the impact of obesity on the risk of depression and, conversely, the impact of depressive disorders on the development and course of obesity. Material and methods: A literature review of scientific publications available in databases (including Google Scholar) was conducted, analyzing data on adolescents and adults with respect to pathophysiological and behavioral mechanisms. The review includes 24 articles published between 2006 and 2025. Results: Individuals with obesity have a 55% higher risk of developing depression, whereas patients with depression are 58% more likely to develop obesity. The prevalence of depression in the population of individuals with obesity is increased, and a modifying effect of sex is observed. Key mechanisms include dysregulation of the HPA axis, chronic inflammation, and disturbances in neurotransmission. Conclusions: Effective treatment requires an integrated approach combining weight reduction with psychological interventions. Treatment of obesity may lead to an improvement in mood.